Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fahn

Showing results (221-230 of 407) with videos related to

Pageof 41
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degenerationS Frucht, S Fahn, S Chin, et al.
Neuropharmacology|March 1, 1984
Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brainD H Jiang, A Reches, H R Wagner, et al.
Biochemical Pharmacology|April 1, 1979
Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administrationS Fahn, R Comi, S R Snider, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1993
Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell lineB Pardo, M A Mena, S Fahn, et al.
Brain Research|December 29, 1987
Differential changes in 125I-LSD-labeled 5-HT-2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN): evidence from autoradiographic studiesJ L Cadet, B Kuyatt, S Fahn, et al.
Advances in Neurology|January 1, 1988
Distant effects of locally injected botulinum toxin: incidence and courseD J Lange, M F Brin, S Fahn, et al.
Neurology|May 1, 1976
Primary sensory symptoms in parkinsonismS R Snider, S Fahn, W P Isgreen, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Further experiences with low doses of bromocriptine in Parkinson's diseaseS Fahn, L J Côté, R E Barrett, et al.
Journal of Pharmaceutical Sciences|November 1, 1984
Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromideA M Crider, T F Hemdi, M N Hassan, et al.
Annals of Neurology|October 1, 1996
Diagnostic guidelines in central nervous system Whipple's diseaseE D Louis, T Lynch, P Kaufmann, et al.
Pageof 41

Showing results (221-230 of 407) with videos related to

Sort By:
Pageof 41
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degenerationS Frucht, S Fahn, S Chin, et al.
Neuropharmacology|March 1, 1984
Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brainD H Jiang, A Reches, H R Wagner, et al.
Biochemical Pharmacology|April 1, 1979
Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administrationS Fahn, R Comi, S R Snider, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1993
Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell lineB Pardo, M A Mena, S Fahn, et al.
Brain Research|December 29, 1987
Differential changes in 125I-LSD-labeled 5-HT-2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN): evidence from autoradiographic studiesJ L Cadet, B Kuyatt, S Fahn, et al.
Advances in Neurology|January 1, 1988
Distant effects of locally injected botulinum toxin: incidence and courseD J Lange, M F Brin, S Fahn, et al.
Neurology|May 1, 1976
Primary sensory symptoms in parkinsonismS R Snider, S Fahn, W P Isgreen, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Further experiences with low doses of bromocriptine in Parkinson's diseaseS Fahn, L J Côté, R E Barrett, et al.
Journal of Pharmaceutical Sciences|November 1, 1984
Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromideA M Crider, T F Hemdi, M N Hassan, et al.
Annals of Neurology|October 1, 1996
Diagnostic guidelines in central nervous system Whipple's diseaseE D Louis, T Lynch, P Kaufmann, et al.
Pageof 41